INFUSYSTEM HOLDINGS, INC Operating Lease Liability
INFUSYSTEM HOLDINGS, INC (INFU) had Operating Lease Liability of $4.11 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability $4.11M.
- 2026-03-31: Operating Lease, Liability $4.46M.
- 2025-12-31: Operating Lease, Liability $4.82M.
- 2025-09-30: Operating Lease, Liability $5.18M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $4.11M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $4.46M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $4.82M 10-K · filed 2026-02-27 |
| 2025-09-30 | $5.18M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.54M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $5.92M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.04M 10-K · filed 2025-03-11 |
| 2024-09-30 | $6.40M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.51M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $6.87M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $7.27M 10-K · filed 2024-04-10 |
| 2023-09-30 | $4.82M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.93M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.83M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $4.69M 10-K · filed 2023-03-16 |
| 2022-09-30 | $4.95M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $5.20M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.37M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.67M 10-K · filed 2022-03-15 |
| 2021-09-30 | $4.26M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.76M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.83M 10-K · filed 2021-03-22 |
| 2020-09-30 | $5.14M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $5.37M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $5.72M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.05M 10-K · filed 2020-03-30 |
| 2019-09-30 | $5.26M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.39M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.79M 10-Q · filed 2019-05-15 |
| 2019-01-01 | $3.10M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |